Congenital sideroblastic anemia due to mutations in the mitochondrial HSP70 homologue HSPA9

K Schmitz-Abe, SJ Ciesielski… - Blood, The Journal …, 2015 - ashpublications.org
K Schmitz-Abe, SJ Ciesielski, PJ Schmidt, DR Campagna, F Rahimov, BA Schilke…
Blood, The Journal of the American Society of Hematology, 2015ashpublications.org
The congenital sideroblastic anemias (CSAs) are relatively uncommon diseases
characterized by defects in mitochondrial heme synthesis, iron-sulfur (Fe-S) cluster
biogenesis, or protein synthesis. Here we demonstrate that mutations in HSPA9, a
mitochondrial HSP70 homolog located in the chromosome 5q deletion syndrome 5q33
critical deletion interval and involved in mitochondrial Fe-S biogenesis, result in CSA
inherited as an autosomal recessive trait. In a fraction of patients with just 1 severe loss-of …
Abstract
The congenital sideroblastic anemias (CSAs) are relatively uncommon diseases characterized by defects in mitochondrial heme synthesis, iron-sulfur (Fe-S) cluster biogenesis, or protein synthesis. Here we demonstrate that mutations in HSPA9, a mitochondrial HSP70 homolog located in the chromosome 5q deletion syndrome 5q33 critical deletion interval and involved in mitochondrial Fe-S biogenesis, result in CSA inherited as an autosomal recessive trait. In a fraction of patients with just 1 severe loss-of-function allele, expression of the clinical phenotype is associated with a common coding single nucleotide polymorphism in trans that correlates with reduced messenger RNA expression and results in a pseudodominant pattern of inheritance.
ashpublications.org